Leveraging the Structure of DNAJA1 to Discover Novel Potential Pancreatic Cancer Therapies

Pancreatic cancer remains one of the deadliest forms of cancer with a 5-year survival rate of only 11%. Difficult diagnosis and limited treatment options are the major causes of the poor outcome for pancreatic cancer. The human protein DNAJA1 has been proposed as a potential therapeutic target for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Roth, Heidi E., De Lima Leite, Aline, Palermo, Nicolas Y., Powers, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599757/
https://www.ncbi.nlm.nih.gov/pubmed/36291603
http://dx.doi.org/10.3390/biom12101391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599757/
https://www.ncbi.nlm.nih.gov/pubmed/36291603
http://dx.doi.org/10.3390/biom12101391

Ejemplares similares